Unfortunately, for us as ultimate consumers or patients, the problem remains the same -- We are still taking pills without ...
More than 50 drugs which include paracetamol, Calcium, vitamin D3 supplements, anti-diabetes pills, and high blood pressure ...
In a recent quality control check by the Central Drugs Standard Control Organization has raised concerns over the safety and ...
FDA alerts in gastroenterology over the summer included an approval for a biosimilar for IBD & new indications for nonerosive ...
India's drug regulator, which releases a monthly list of substandard or fake medicines sold in the country, said it found ...
The U.S. Food & Drug Administration has accepted Aptar Pharma's N-Sorb nitrosamine mitigation solution into its Emerging ...
Phathom Pharmaceuticals developed Voquezna, a first-in-class PCAB, licensed from Takeda, for acid-related disorders. Find out ...
Apart from hurting at the domestic level, the trend will further tarnish the reputation of India in the global arena ...
There is an urgent need to strengthen the regulatory framework, ensuring regular and more frequent inspections to address ...
An anonymous source in the CDSCO according to ANI said, “Such [a] list is released every month and this shows that the Drugs ...
The pharma major has refuted the findings, clarifying that a batch of Shelcal 500 drug that failed the CDSCO test has not ...
India's drug regulator has found more than 50 drugs, including some batches of widely used antacids and paracetamol, to be ...